Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Aura Biosciences Inc., 3 years.
Aura Biosciences Inc.
Director
Zentalis Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 21, 2024 | Zentalis Pharmaceuticals Inc. | Grant or award | +48,429 | — | — |
| Jun 20, 2024 | Aura Biosciences Inc. | Grant or award | +10,500 | — | — |
| Nov 10, 2023 | Zentalis Pharmaceuticals Inc. | Open-market purchase | +17,000 | $9.88 | $167,960 |
| Nov 8, 2023 | Aura Biosciences Inc. | Open-market purchase | +9,601 | $7.30 | $70,087 |
| Nov 8, 2023 | Aura Biosciences Inc. | Open-market purchase | +10,000 | $7.30 | $73,000 |
| Nov 8, 2023 | Aura Biosciences Inc. | Open-market purchase | +10,000 | $7.30 | $73,000 |
| Nov 7, 2023 | Aura Biosciences Inc. | Open-market purchase | +76,000 | $7.17 | $544,920 |
| Nov 7, 2023 | Aura Biosciences Inc. | Open-market purchase | +47,000 | $7.17 | $336,990 |
| Nov 7, 2023 | Aura Biosciences Inc. | Open-market purchase | +47,000 | $7.17 | $336,990 |
| Oct 4, 2023 | Aura Biosciences Inc. | Open-market purchase | +6,566 | $8.61 | $56,533 |
| Oct 3, 2023 | Aura Biosciences Inc. | Open-market purchase | +13,500 | $8.27 | $111,645 |
| Jun 16, 2023 | Zentalis Pharmaceuticals Inc. | Grant or award | +19,059 | — | — |
| Jan 6, 2023 | Aura Biosciences Inc. | Open-market purchase | +700 | $10.50 | $7,350 |
| Jan 6, 2023 | Aura Biosciences Inc. | Open-market purchase | +904 | $10.51 | $9,501 |
| Jan 5, 2023 | Aura Biosciences Inc. | Open-market purchase | +300 | $10.00 | $3,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.